Cargando…
Active recruitment of anti–PD-1–conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapy
Immune checkpoint inhibitors (ICIs) can reinvigorate T cells to eradicate tumor cells, showing great potential in combating various types of tumors. We propose a delivery strategy to enhance tumor-selective ICI accumulation, which leverages the responsiveness of platelets and platelet-derivatives to...
Autores principales: | Wang, Yixin, Li, Wen, Li, Zhaoting, Mo, Fanyi, Chen, Yu, Iida, Mari, Wheeler, Deric L, Hu, Quanyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058243/ https://www.ncbi.nlm.nih.gov/pubmed/36989364 http://dx.doi.org/10.1126/sciadv.adf6854 |
Ejemplares similares
-
Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases
por: Liu, Jun, et al.
Publicado: (2022) -
PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
por: Huang, Changsheng, et al.
Publicado: (2023) -
Switchable immune modulator for tumor-specific activation of anticancer immunity
por: Zhao, Yu, et al.
Publicado: (2021) -
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity
por: Savage, Thomas M., et al.
Publicado: (2023) -
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
por: Wan, Zhuoya, et al.
Publicado: (2021)